Related Experiment Video
Updated: Jun 26, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Expression of the p16INK4A/Cdkn2a gene is prevalently downregulated in human pheochromocytoma tumor specimens
Peter Muscarella1, Mark Bloomston, Alexander R Brewer
1Department of Surgery, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Abstract:
A number of hereditary syndromes have been found to be associated with pheochromocytoma development, but there is a paucity of data regarding secondary molecular events, such as downregulation of the p16INK4A/Cdkn2a gene (hereafter p16), contributing to pheochromocytoma tumorigenesis. Using tissue microarray and immunohistochemistry, we evaluated the expression of p16 in 31 pheochromocytoma tumor specimens. Our results showed that the p16 gene was expressed at low level or even not expressed in all but one specimens [30/31 (96.8%)], indicative of the prevalence of p16 downregulation in pheochromocytomas. In contrast, high expression of pl6 was observed in the majority of control "normal" specimens [5/7 (71.6%)]. To further investigate the molecular mechanisms underlying pl6 downregulation in pheochromocytomas, we used quantitative real-time PCR, methylation-specific PCR, and direct DNA sequencing to analyze these specimens for potential genetic alterations of the p16 gene. Deletions and aberrant CpG methylation of pl6 were identified in 9 (29.0%) and 11 (35.5%) specimens, respectively, while one specimen harbored a point mutation, Ala --> Pro at residue 20 of P16, and this mutation led to an eightfold decrease in the CDK4-inhibitory activity of P16. The overall frequency of pl6 genetic alterations is 67.7%. Taken together, our results demonstrate that reduced expression of pl6 is a common event in human pheochromocytomas, and the primary cause for such downregulation is inactivating genetic abnormalities in the p16 gene.
Insights
Reduced expression of the p16INK4A/Cdkn2a gene (p16) is common in pheochromocytomas. Inactivating genetic abnormalities, including deletions, methylation, and mutations, are the primary cause of this p16 downregulation in tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hereditary syndromes are linked to pheochromocytoma.
- Secondary molecular events in pheochromocytoma tumorigenesis are understudied.
- The role of the p16INK4A/Cdkn2a (p16) gene in pheochromocytoma is not well understood.
Purpose of the Study:
- To investigate the expression and molecular alterations of the p16 gene in pheochromocytoma.
- To determine the frequency and mechanisms of p16 downregulation in pheochromocytoma development.
Main Methods:
- Tissue microarray and immunohistochemistry were used to assess p16 expression in 31 pheochromocytoma specimens and 7 normal controls.
- Quantitative real-time PCR, methylation-specific PCR, and direct DNA sequencing were employed to analyze genetic alterations of the p16 gene.
Main Results:
- p16 was downregulated in 96.8% of pheochromocytoma specimens, contrasting with high expression in 71.6% of normal controls.
- Genetic alterations, including deletions (29.0%), aberrant CpG methylation (35.5%), and a point mutation affecting CDK4-inhibitory activity, were identified in the p16 gene.
- The overall frequency of p16 genetic alterations was 67.7%.
Conclusions:
- Reduced p16 expression is a frequent event in human pheochromocytomas.
- Inactivating genetic abnormalities of the p16 gene are the main drivers of its downregulation in pheochromocytoma.
- These findings highlight the significance of p16 alterations in pheochromocytoma tumorigenesis.
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules